Lack of Concomitant Expression of ICAM-1 and HLA-DR on Bile Duct Cells from Patients with Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 28 (2) , 126-130
- https://doi.org/10.3109/00365529309096058
Abstract
In both primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) prominent infiltrates of lymphocytes surround the bile ducts, on which an abberrant expression of major histocompatibility complex class II antigens has been found, suggesting that the immune system is involved in the biliary destruction. Since the lymphocytes presumably must adhere to the bile ducts to initiate a cell-to-cell-mediated destruction, we have studied the expression of the lymphocyte function-associated antigen-1 (LFA-1) together with its ligand, the intercellular adhesion molecule-1 (ICAM-1), and the expression of HLA-DR, using immunoperoxidase staining of cryostat sections from patients with PBC (n = 10), PSC (n = 13), and normal healthy controls (n = 6). Most lymphocytes expressed LFA-1. ICAM-1 expression was found on hepatocytes from 9 of 10 PBC and 10 of 13 PSC patients but was not seen on hepatocytes from the controls. Hepatocytes expressing HLA-DR were only found in one patient with PBC. None of the septal bile ducts expressed ICAM-1, and only one PSC patient and three PBC patients expressed ICAM-1 on their interlobular bile ducts. The bile ducts in 22 of 23 patients, however, expressed HLA-DR. Proliferating bile ductules from two PBC patients and three PSC patients showed a concomitant expression of ICAM-1 and HLA-DR. None of the bile ducts from the controls expressed ICAM-1 or HLA-DR. Thus, since most bile ducts involved in the disease process of both PBC and PSC lack expression of ICAM-1, other adhesion molecules must be involved if a cell-to-cell-mediated destruction accounts for the biliary destruction in these two disease states. Furthermore, the lack of concomitant expression of HLA-DR and ICAM-1 on the bile ducts in PBC and PSC indicates that other regulatory mechanisms exist in the biliary epithelium than in most other epithelial cells.Keywords
This publication has 18 references indexed in Scilit:
- Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.The Journal of Experimental Medicine, 1991
- Gastric Epithelial Cells in Helicobacter pylori‐Associated Gastritis Express HLA‐DR but not ICAM‐1Scandinavian Journal of Immunology, 1991
- Immunohistochemical Study of Adhesion Molecules in Liver InflammationHepatology, 1990
- Distribution of HLA-DR, HLA-DP, HLA-DQ Antigens in Liver Tissue from Patients with Primary Sclerosing CholangitisScandinavian Journal of Gastroenterology, 1990
- Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: An in Vitro studyHepatology, 1989
- Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cellsJournal of Endocrinology, 1989
- Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factorJournal of the American Academy of Dermatology, 1989
- Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosisHepatology, 1988
- Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosisHepatology, 1986
- Immunologic Analysis of Mononuclear Cells in Liver Tissues and Blood of Patients With Primary Sclerosing CholangitisHepatology, 1985